Additionally, in CML-AP/BC (accelerated phase/blast crisis), which clinically behaves like AML, VSTM1 expression levels were much lower than those in CML-CP (chronic phase, P = 0.003, Table 1). The gene discussed is VSTM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.